Preferred Label : Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type
a, 5;
Symbol : MDDGA5;
CISMeF acronym : MDDGA5;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Walker-warburg syndrome or muscle-eye-brain disease, fkrp-related;
Description : Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type
A), which includes both the more severe Walker-Warburg syndrome (WWS) and the slightly
less severe muscle-eye-brain disease (MEB), is an autosomal recessive disorder with
characteristic brain and eye malformations, profound mental retardation, congenital
muscular dystrophy, and death usually in the first years of life. It represents the
most severe end of a phenotypic spectrum of similar disorders resulting from defective
glycosylation of DAG1 (128239), collectively known as 'dystroglycanopathies' (Beltran-Valero
de Bernabe et al., 2004). For a general phenotypic description and a discussion of
genetic heterogeneity of muscular dystrophy-dystroglycanopathy type A, see;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the fukutin-related protein gene (FKRP, 606596.0016);
Laboratory abnormalities : Increased serum creatine kinase;
Prefixed ID : #613153;
Origin ID : 613153;
UMLS CUI : C3150413;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)